About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 7204 record(s)
Req # A-2024-000300
For November 6, 2019, all meeting notes, briefing notes and memoranda sent or received by the Deputy Minister regarding the Hazardous Products Act, including its true copy of a label requirement.Organization: Health Canada
January 2025
Req # A-2024-000443
Records related to meetings about Dying With Dignity Canada or between Health Canada/Dying With Dignity Canada, emails about Dying With Dignity Canada or between Health Canada/Dying With Dignity Canada, and documents prepared about Dying With…Organization: Health Canada
January 2025
Req # A-2024-000533
All correspondence or other records, whether authored by Health Canada, or a sponsor/manufacturer, relating to any pre-submission or pre-application meeting(s) requested by a sponsor in respect of a drug submission/application for a product…Organization: Health Canada
January 2025
Req # A-2024-000544
A screenshot of the status page for the March 2024 Semaglutide Abbreviated New Drug Submission (ANDS) on the Drug Submission Tracking System (DSTS) interface.Organization: Health Canada
January 2025
Req # A-2024-000545
any records with respect to the November 2023 Liraglutide Abbreviated New Drug Submission (ANDS) which describe any mechanism of route administration.Organization: Health Canada
January 2025
Req # A-2024-000547
Correspondence relating to any Abbreviated New Drug Submission (ANDS) accepted into in March 2024 where the medicinal ingredient is semaglutide and the correspondence mentions “Canadian Reference Product.”Organization: Health Canada
January 2025
Req # A-2024-000575
All research papers, and associated data communicated by Dr. David Hammond to Health Canada on or related to the topic of cannabis. Time frame: October 17, 2018 to August 28, 2024Organization: Health Canada
January 2025
Req # A-2024-000599
All Health Canada Seizure and Disposition Reports submitted by the Grand Prairie, Alberta Royal Canadian Mounted Police (RCMP) from March 1, 2020 to August 31, 2022 where the place of seizure, finding, acquisition as indicated in Box 6 of the form…Organization: Health Canada
January 2025
Req # A-2024-000624
All information on medical device recalls relating to the below medical devices, including the date of the recall(s) and reason(s) for the recall(s): Medtronic, model# Evera MRI DR DDMC3D4; Medtronic, model# Evera MR1 DR DDMC3D4; Medtronic, model#…Organization: Health Canada
January 2025
Req # A-2024-000630
All correspondence between registered lobbyist Sheila Copps and Health Canada employee Pierre Sabourin between January 1, 2020, and December 31, 2022.Organization: Health Canada
January 2025